By Counterforce Health Team in Signifor / Signifor LAR (pasireotide) —

How to Get Signifor LAR (Pasireotide) Covered by Humana in Ohio: Complete Appeal Guide with Templates

Answer Box: Getting Signifor LAR Covered by Humana in Ohio

Fastest path: Check if your Humana plan requires prior authorization for pasireotide using their Prior Authorization Search Tool. Submit complete clinical documentation including UFC/IGF-1 levels, failed surgery/first-line therapies, and endocrinologist prescription. If denied, request peer-to-peer review within 65 days, then file external review through Ohio Department of Insurance within 180 days of final denial.

Start today: Gather your insurance card, denial letter (if applicable), lab results, and treatment history. Contact your endocrinologist to verify prior authorization status.

Table of Contents

  1. Understanding Humana's Coverage for Signifor LAR
  2. Prior Authorization Requirements
  3. Common Denial Reasons and How to Fix Them
  4. Step-by-Step Appeal Process
  5. Peer-to-Peer Review Strategy
  6. Ohio External Review Process
  7. Medical Necessity Letter Template
  8. Cost-Saving Options
  9. When to Contact Ohio Regulators
  10. FAQ

Understanding Humana's Coverage for Signifor LAR

Signifor LAR (pasireotide) is a second-generation somatostatin analog used for Cushing's disease and acromegaly when surgery isn't curative or feasible. Humana Medicare Advantage plans generally require prior authorization for this high-cost specialty medication.

Coverage Determination: Part B vs Part D

The coverage pathway depends on how Signifor LAR is administered:

  • Part B (Medical Benefit): When administered in physician offices or outpatient facilities
  • Part D (Prescription Benefit): When dispensed by specialty pharmacies for self-administration

Many Humana formularies flag pasireotide as "Part B vs Part D (BvsD)", requiring clinical documentation to determine the appropriate benefit.

Tip: Never assume coverage without verification. Contact Humana at 800-555-CLIN (2546) to confirm which benefit applies to your specific situation.

Prior Authorization Requirements

Clinical Criteria for Approval

Based on typical Humana policies and industry standards, approval requires:

For Cushing's Disease:

  • Age ≥18 years
  • Documented pituitary-dependent hypercortisolism via elevated UFC, late-night salivary cortisol, or abnormal dexamethasone suppression test
  • Failed or unsuitable for transsphenoidal surgery
  • Prescription by or consultation with endocrinologist

For Acromegaly:

  • Confirmed diagnosis with elevated age-adjusted IGF-1 and/or GH
  • Inadequate response to surgery or not surgical candidate
  • Failed or intolerant to first-generation somatostatin analogs (octreotide LAR, lanreotide)
  • Planned dosing within FDA-approved limits

Required Documentation

Document Type Specific Requirements Where to Find
Diagnostic Labs UFC levels, IGF-1 with reference ranges Endocrinology records
Surgery Records Op notes, post-op hormone levels Hospital/surgeon records
Prior Therapies Octreotide/lanreotide trials with outcomes Pharmacy records, clinic notes
Prescriber Info Board certification, specialty Medical license verification

Common Denial Reasons and How to Fix Them

Denial Reason Solution Required Documentation
"Not medically necessary" Submit detailed treatment history Prior therapy failures, contraindications
"Step therapy not met" Document first-line therapy trials Pharmacy records, IGF-1 levels on treatment
"Non-formulary drug" Request formulary exception Comparative effectiveness data
"Quantity limits exceeded" Justify dosing based on weight/response Clinical notes, FDA labeling
"Non-specialist prescriber" Obtain endocrinology consultation Referral letter, co-signature

Step-by-Step Appeal Process

Level 1: Internal Appeal (Redetermination)

Timeline: Must file within 65 days of denial notice

  1. Gather Materials (Patient/Family)
    • Original denial letter
    • Insurance card and member ID
    • Complete medical records
  2. Submit Request (Prescriber)
  3. Follow Up (Both)
    • Standard decision: 72 hours for Part D, 30 days for Part B
    • Track status through provider portal

Level 2: Independent Review

If the internal appeal is denied, you have 65 days to request an independent review through Humana's contracted review organization.

Important: Keep detailed records of all communications, including dates, reference numbers, and representatives' names.

Peer-to-Peer Review Strategy

Requesting a Peer-to-Peer Call

When Humana issues a denial, prescribers can request a clinical discussion with a plan physician. This often resolves denials without formal appeals.

Script for Clinic Staff: "I'm calling to schedule a peer-to-peer review for [patient name], member ID [number]. We received a denial for Signifor LAR, and Dr. [name] would like to discuss the clinical rationale with your reviewing physician."

Preparation Checklist for Prescribers

  • Patient's complete hormone levels (baseline and on prior treatments)
  • Detailed surgical history and outcomes
  • Documentation of first-line therapy failures or contraindications
  • Current symptoms and functional impairment
  • Relevant guidelines supporting second-line somatostatin analog use

Key Talking Points

  1. Emphasize FDA-approved indication: "This is an on-label use for Cushing's disease/acromegaly in a patient who meets all criteria."
  2. Document step-therapy compliance: "Patient failed octreotide LAR at maximum tolerated dose with persistent IGF-1 elevation at 2.3 times upper normal."
  3. Highlight safety considerations: "First-generation analogs caused significant gallbladder complications requiring discontinuation."

Ohio External Review Process

If Humana upholds the denial after internal appeals, Ohio residents can request an external review through an Independent Review Organization (IRO).

Eligibility and Timing

  • Deadline: 180 days from final denial notice
  • Eligible cases: Medical necessity denials, experimental/investigational determinations
  • Cost: No charge to patients

How to Request External Review

  1. Standard Review
    • Submit written request to Humana following instructions in denial notice
    • Include all supporting medical records
    • Decision within 30 days
  2. Expedited Review
    • Available when delay could jeopardize health
    • Can be requested orally with written follow-up within 5 days
    • Decision within 72 hours

Ohio Department of Insurance Support

Contact ODI Consumer Services at 1-800-686-1526 for assistance with external review questions or to file complaints about insurer non-compliance.

Medical Necessity Letter Template

Essential Components

Patient Information & Diagnosis "[Patient name] is a [age]-year-old with biochemically confirmed [Cushing's disease/acromegaly] diagnosed on [date] based on [specific lab values with reference ranges]."

Treatment History "Following unsuccessful transsphenoidal surgery on [date], patient was treated with [first-line therapy] at [dose] for [duration]. Despite optimal dosing, [hormone levels] remained elevated at [specific values], indicating inadequate biochemical control."

Medical Necessity Statement "Given persistent hypercortisolism/IGF-1 elevation despite conventional therapy and surgical failure, pasireotide LAR represents guideline-concordant second-line medical therapy within its FDA-approved indication."

Monitoring Plan "Patient will be monitored with quarterly hormone levels, glucose monitoring for hyperglycemia, and gallbladder ultrasound every 6 months per standard protocols."

From our advocates: We've seen the strongest approvals when prescribers include specific numerical values (UFC decreased from 3.2× to 1.4× upper normal) rather than vague statements like "improved." Payers want objective data to justify continued coverage.

Cost-Saving Options

Manufacturer Support Programs

  • Recordati Rare Diseases Patient Support: Verify current programs for copay assistance and free drug programs
  • Eligibility: Typically available for commercially insured patients with coverage gaps

Foundation Assistance

  • Patient Advocate Foundation: Provides case management and financial assistance
  • National Organization for Rare Disorders (NORD): Offers patient assistance programs for rare disease medications

State Programs

Ohio residents may qualify for additional support through state pharmaceutical assistance programs. Contact the Ohio Department of Commerce for current options.

When to Contact Ohio Regulators

File a Complaint When:

  • Humana fails to respond within required timeframes
  • You're incorrectly told external review isn't available
  • The insurer doesn't provide required appeal forms or information

Ohio Department of Insurance Complaint Process

  1. Online: Submit through the ODI website complaint portal
  2. Phone: Call 1-800-686-1526 during business hours
  3. Mail: Send written complaint with supporting documents

Include your member ID, denial letters, timeline of communications, and specific resolution sought.

FAQ

Q: How long does Humana prior authorization take for Signifor LAR in Ohio? A: Standard reviews take up to 72 hours for Part D coverage, 30 days for Part B. Expedited reviews are completed within 24-72 hours when medically urgent.

Q: What if Signifor LAR is non-formulary on my Humana plan? A: You can request a formulary exception by demonstrating medical necessity and failure of formulary alternatives. This requires detailed clinical documentation.

Q: Can I request an expedited appeal if my condition is worsening? A: Yes, if waiting for standard review timelines could seriously jeopardize your health. Your prescriber must provide supporting clinical documentation.

Q: Does step therapy apply if I've already failed first-line treatments outside Ohio? A: Yes, documented treatment failures from any location should satisfy step therapy requirements. Ensure your new Ohio provider has complete records.

Q: What's the success rate for external reviews in Ohio? A: Ohio follows national standards where Independent Review Organizations overturn approximately 25-30% of insurer denials, with higher rates for rare disease medications.

Q: Can I continue treatment while appeals are pending? A: Not typically, unless you pay out-of-pocket or qualify for manufacturer assistance programs. Discuss temporary coverage options with your prescriber.

At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters, plan policies, and clinical notes to create targeted, evidence-backed appeals that align with each payer's specific requirements. By pulling the right citations and weaving them into compelling medical necessity arguments, we help ensure patients get access to the treatments they need.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions are complex and vary by plan. Always consult with your healthcare provider and insurance plan directly for guidance specific to your situation. For official Ohio insurance regulations and appeal procedures, contact the Ohio Department of Insurance.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.